Tuberculosis of Lymph Node Combined with Pulmonary Mucormycosis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Disseminated tuberculosis and gastric mucormycosis coinfection.
Malek A, De La Hoz A, Arduino R, Aisenberg G IDCases. 2019; 18:e00595.
PMID: 31360637 PMC: 6639657. DOI: 10.1016/j.idcr.2019.e00595.
Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.
Feng J, Sun X Infection. 2018; 46(4):503-512.
PMID: 29748841 DOI: 10.1007/s15010-018-1149-x.
References
1.
Kontoyiannis D, Lewis R, Lortholary O, Lotholary O, Spellberg B, Petrikkos G
. Future directions in mucormycosis research. Clin Infect Dis. 2012; 54 Suppl 1:S79-85.
PMC: 3258101.
DOI: 10.1093/cid/cir886.
View
2.
Spellberg B, Ibrahim A
. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep. 2011; 12(6):423-9.
PMC: 2947016.
DOI: 10.1007/s11908-010-0129-9.
View
3.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh T, Kontoyiannis D
. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1:S23-34.
DOI: 10.1093/cid/cir866.
View
4.
Okubo Y, Ishiwatari T, Izumi H, Sato F, Aki K, Sasai D
. Pathophysiological implication of reversed CT halo sign in invasive pulmonary mucormycosis: a rare case report. Diagn Pathol. 2013; 8:82.
PMC: 3658989.
DOI: 10.1186/1746-1596-8-82.
View
5.
Spellberg B, Ibrahim A, Roilides E, Lewis R, Lortholary O, Petrikkos G
. Combination therapy for mucormycosis: why, what, and how?. Clin Infect Dis. 2012; 54 Suppl 1:S73-8.
PMC: 4542574.
DOI: 10.1093/cid/cir885.
View